Pengaruh Pemberian Omega 3 (EPA+DHA) Terhadap Kadar Gula Darah Penderita Diabetes Melitus Tipe 2 di Kota Kendari
The Effect of Omega 3 (EPA+DHA) Supplementation) on Blood Glucose Level in Type 2 Diabetes Mellitus Patient in Kendari
Abstract
Latar Belakang: Diabetes melitus tipe 2 (T2DM) telah menjadi masalah kesehatan global baik di negara maju maupun negara berkembang. Di Indonesia, prevalensi nasional diabetes meningkat dari 6,9% di tahun 2013 menjadi 8,5% di tahun 2018. Berbagai macam upaya telah dikembangkan guna mengurangi risiko diabetes, diantaranya adalah identifikasi fungsi isoflavone yang berasal dari tumbuh-tumbuhan serta asam lemak tak jenuh Omega 3 seperti eicosapentaenoic acid (EPA) dan docosahexaenoic acid (DHA) yang berasal dari makanan berbasis kelautan. Penelitian ini bertujuan untuk mengetahui pengaruh pemberian Omega 3 komersial (EPA+DHA) terhadap kadar gula darah postprandial penderita DM tipe 2 di Kota Kendari.
Metode: Penelitian ini merupakan penelitian pra eksperimen dengan rancangan one group test pretest-posttest design terhadap 20 penderita DM tipe 2 yang dilaksanakan sejak Agustus sampai Oktober 2021.
Hasil: Hasil penelitian menunjukkan sehingga secara statistik tidak ada perbedaan kadar gula darah postprandial sebelum dan sesudah suplementasi Omega 3 pada pasien diabetes mellitus tipe 2 di Kota Kendari (p value=0.101).
Kesimpulan: Tidak ada perbedaan kadar gula darah postprandial sebelum dan sesudah suplementasi Omega 3 pada pasien diabetes mellitus tipe 2 di Kota Kendari
References
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
Kesehatan K. Riset Kesehatan Dasar (Riskesdas). Kemenkes RI. 2013;
Larsson SC, Wallin A, Håkansson N, Stackelberg O, Bäck M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66–70.
Peters SAE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Springer; 2014.
TIME G. ON DIABETES. 2016;
Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care [Internet]. 2014 Jan 1;37(Supplement 1):S81 LP-S90. Available from: http://care.diabetesjournals.org/content/37/Supplement_1/S81.abstract
Wu JHY, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(S2):S214–27.
Takkunen MJ, Schwab US, de Mello VDF, Eriksson JG, Lindström J, Tuomilehto J, et al. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr [Internet]. 2016;55(3):967–79. Available from: https://doi.org/10.1007/s00394-015-0911-4
Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El-Sohemy A, et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes. 2010 May;3:173–86.
Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ [Internet]. 2019 Aug 21;366:l4697–l4697. Available from: https://pubmed.ncbi.nlm.nih.gov/31434641
Chang C-H, Tseng P-T, Chen N-Y, Lin P-C, Lin P-Y, Chang JP-C, et al. Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins, Leukot Essent Fat Acids [Internet]. 2018;129:1–12. Available from: https://www.sciencedirect.com/science/article/pii/S0952327817302910
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
